about
Testosterone deficiency in the aging maleTestosterone replacement therapy in older adult men.Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease.Hirsutism and the effectiveness of spironolactone in its management.Andropause: clinical implications of the decline in serum testosterone levels with aging in men.Potentiating the cellular targeting and anti-tumor activity of Dp44mT via binding to human serum albumin: two saturable mechanisms of Dp44mT uptake by cells.Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy.The changing role of the clinical laboratory in the investigation of polycystic ovarian syndromeReflections concerning biochemical parameters of androgenicity.Prognostic factors in paediatric anaplastic large cell lymphoma: role of ALK.Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor 1 to growth hormone.Androgen regulation of beta-amyloid protein and the risk of Alzheimer's disease.Sex steroid hormones and cognitive functioning in healthy, older men.Late-onset hypogonadism (LOH) and androgens: validity of the measurement of free testosterone levels in the diagnostic criteria in Japan.Pharmacology of testosterone replacement therapy preparations.Revisiting hyper- and hypo-androgenism by tandem mass spectrometry.Effects of aromatase inhibition vs. testosterone in older men with low testosterone: randomized-controlled trial.Pretreatment of different biological matrices for exogenous testosterone analysis: a review.Bioavailable Testosterone Linearly Declines Over A Wide Age Spectrum in Men and Women From The Baltimore Longitudinal Study of AgingLow testosterone levels associated with venlafaxine use: a case reportAge-related changes in serum and brain levels of androgens in male Brown Norway rats.Interictal hyposexuality in male patients with epilepsy.Sexual dysfunction in the elderly male.The management of hypogonadism in aging male patients.Association of bioavailable estradiol levels and testosterone levels with serum albumin levels in elderly men.The sexual and reproductive health in men with generalized epilepsy: a multidisciplinary evaluation.A time-resolved fluorescence immunoassay for the measurement of testosterone in saliva: monitoring of testosterone replacement therapy with testosterone buciclate.Pharmacokinetics of testosterone in hypogonadal men after transdermal delivery: influence of dose.A mass spectrometric method for quantification of tryptophan-derived uremic solutes in human serum.Bioavailable vitamin D levels are reduced and correlate with bone mineral density and markers of mineral metabolism in adults with nephrotic syndromePractical consequences of the validation of a mathematical model in assessment of partial androgen deficiency in the aging male using bioavailable testosteroneUsefulness and limitation of bioavailable testosterone in assessment of androgenicity during the process of aging in men
P2860
Q26770414-BC225FCA-20F1-48C9-AB4B-4F435954C8CDQ33745729-954D2357-973A-4849-87A3-30F1DD031B4FQ34091893-4928A606-691E-4634-AC6D-7413307026D4Q34338540-41EDB75B-9FFC-4D17-A9E5-020E8F501A61Q34511442-A5D340C5-5E03-401B-9B27-0BF47029602AQ35833012-962D3F57-B4BA-4CFA-A17A-972DF94A989EQ35852422-477DC882-9699-4E76-8893-41F5F1A1984FQ36013372-B4D6E423-CB17-42E6-9C96-4D3007649D20Q36084032-14558B1F-CCCC-4859-9B85-748E97FB0E47Q36436653-1B3AC560-C080-4A00-A595-15957FA29A3AQ36660056-CCF92CC2-7131-4859-B7DC-97002E1BD669Q36666722-3D8B2717-AD9B-4A80-81D9-CCC3C18D6CEFQ36827276-D404C310-435C-4E6A-9666-8090B0DE6335Q37340641-E4149AE5-3CEC-40FA-BA16-ABE9EF435613Q37531077-16EF6C36-FC16-4F72-9A24-418E07406A4FQ38101855-43DBCCA4-AD3A-4FA5-AF88-9BA399D669CCQ38940702-6F3AE2B6-2F13-4DC9-ADBD-1BD4971182AEQ39415861-54CC49DC-96E8-4F74-A8E1-0056FE2E4046Q39963703-6FD73E02-31C8-431D-8FC4-7460642FCACEQ41880170-BBC0440F-F70E-4A80-8DBF-15189E231FBBQ43261342-94BBBD33-63D8-4B9F-8889-0244019C4EECQ43572985-7B01E552-88C1-4AFD-A804-7782C88CA2B9Q46120105-32BC9249-CB66-476D-BC8C-DB51CEA7FB1FQ46140539-47CAAC79-8248-49E4-9E63-AD8AAF302D9AQ46526831-D2BD455E-334F-4F1F-82B6-6706DB727D6FQ46665311-151217C3-2865-4E2E-8B1A-4FC29F662DBAQ47933850-96DBB0E6-4459-4F9F-8159-D01BDEA82239Q50998640-714F7383-912B-465B-ACF9-9DC40C30BDA6Q55355974-06D248A3-9222-413B-9BF2-71420C2DF49AQ57370876-48529BE6-F91E-48D9-A127-2AE382FAF667Q58159248-C155E3B9-9E5A-4AE4-8D03-6A431F355CE5Q58253846-C8710BD1-FB6A-4779-B30D-27EDC9A3AC59
P2860
description
1985 nî lūn-bûn
@nan
1985 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
name
Bioavailability of albumin-bound testosterone.
@ast
Bioavailability of albumin-bound testosterone.
@en
Bioavailability of albumin-bound testosterone.
@nl
type
label
Bioavailability of albumin-bound testosterone.
@ast
Bioavailability of albumin-bound testosterone.
@en
Bioavailability of albumin-bound testosterone.
@nl
prefLabel
Bioavailability of albumin-bound testosterone.
@ast
Bioavailability of albumin-bound testosterone.
@en
Bioavailability of albumin-bound testosterone.
@nl
P2093
P356
P1476
Bioavailability of albumin-bound testosterone.
@en
P2093
P304
P356
10.1210/JCEM-61-4-705
P407
P577
1985-10-01T00:00:00Z